@inproceedings{inproceedings, title = {{Efficacy and safety of dupilumab in children aged >= 6 months to < 6 years with moderate-to-severe atopic dermatitis}}, url = {{}}, year = {{2022}}, month = {{1}}, author = {{Paller AS and Cork MJ and Siegfried EC and Simpson EL and Wollenberg A and Gonzalez ME and Sun Y and O'Malley JT and Bansal A}}, volume = {{187}}, journal = {{BRITISH JOURNAL OF DERMATOLOGY}}, pages = {{12-12}}, note = {{Accessed on 2025/05/24}}}